The Collagen Tripeptide Supplement industry trends have evolved rapidly over the past 18 months, driven by innovation and shifting consumer priorities. Strategic partnerships, such as NutriTech Global collaborating with BioPeptide Labs to enhance hydrolyzed collagen absorption, highlight efforts to improve efficacy. In M&A, CollagenPlus Inc. acquired VitaStem Biologics, expanding its portfolio into medical-grade collagen therapies. Product launches, including DermaGlowโs collagen-vegan gummy line and PeptiCareโs cold-pressed collagen powders, reflect demand for clean-label and functional formats. Regulatory changes, such as the EUโs updated food supplement guidelines requiring stricter bioavailability testing, have prompted reformulations across the industry. Consumer trends now emphasize sustainability, with 58% of buyers preferring brands using eco-friendly packaging, while demand for joint and skin health claims remains robust. Meanwhile, CollagenBio secured $20M in Series C funding to scale production, signaling investor confidence in the sectorโs growth potential. These developments underscore a dynamic market poised for expansion through R&D and sustainability-driven strategies.